Commercializing Deep Tech: IP, startups, and getting to market
Join U of T's Innovations & Partnerships Office (IPO) for a lunch and learn discussion on commercializing science.
From protecting your IP to customer pilots and creating a deep tech startup, we'll cover real-world best practices and tales from the frontlines, directly from U of T Entrepreneurs and experts.
Format:
Intro to commercialization in the U of T Ecosystem
Panel discussion featuring Mike Cooke, CEO and Co-founder of AmacaThera, a clinical-stage biotech spinout, and Helen Kontozopoulos, serial founder (Resiin, ODAIA) and Adjunct Prof. in the Department of Computer Science, and other go-to-market experts.
Q&A and networking
Lunch and refreshments provided
Who should attend? U of T Faculty, undergrad and graduate students, post-grads, and startups interested in bringing deep tech to market.
Why attend? Learn more about commercializing U of T Research, building industry and investor connections, creating a startup, and meet the supporters that can help make it happen.
More
The Innovations & Partnerships Office (IPO) is your first stop for research commercialization at U of T. IPO helps U of T Inventors patent, market, license, and create statups around their research, and builds successful relationships among industry and investors.
AmacaThera is a leading developer of next-gen hydrogel-based drug delivery solutions for precise, tunable, and sustained release of a wide range of therapeutics, from small molecules to biologics. The company has completed a successful Phase 1 clinical trial and raised over US$13M in financing, while also establishing several key strategic partnerships, including an exclusive licensing agreement with Pacira BioSciences for up to $230M.
This event is part of U of T Entrepreneurship Week 2026.